October 08, 2019
GenSight Biologics Appoints Magali Taiel as Chief Medical Officer
Media
October 08, 2019
GenSight Biologics to present new GS010 data at the 2019 Annual Meeting of the American Academy of Ophthalmology
October 07, 2019
Aprea Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 07, 2019
Nordic Nanovector signs global clinical and commercial agreement with ITM for the supply of no-carrier-added Lutetium-177
October 03, 2019
Vicore Pharma announces the Nomination Committee for the 2020 Annual General Meeting
October 02, 2019
Aprea Therapeutics Announces Pricing of Initial Public Offering
October 01, 2019
Update on progress in clinical lead program VP01 (C21)
October 01, 2019
GenSight Biologics integrates the Enternext® PEA-PME 150 index by Euronext
October 01, 2019
Nordic Nanovector appoints Dr Gabriele Elbl as Vice President Global Regulatory Affairs
September 26, 2019
Patient recruitment in the Pivotal Phase 2-Study HORIZON completed
